Symbol="CARA"
AssetType="Common Stock"
Name="Cara Therapeutic"
Description="Cara Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on itching and pain by selectively targeting kappa opioid receptors in the United States. The company is headquartered in Stamford, Connecticut."
CIK="1346830"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="4 STAMFORD PLAZA, 107 ELM STREET 9TH FLOOR, STAMFORD, CT, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="144135000"
EBITDA="-87031000"
PERatio="None"
PEGRatio="0"
BookValue="2.531"
DividendPerShare="0"
DividendYield="0"
EPS="-1.46"
RevenuePerShareTTM="0.805"
ProfitMargin="-1.952"
OperatingMarginTTM="-2.018"
ReturnOnAssetsTTM="-0.289"
ReturnOnEquityTTM="-0.495"
RevenueTTM="43242000"
GrossProfitTTM="-56141000"
DilutedEPSTTM="-1.46"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.287"
AnalystTargetPrice="17.86"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="15.22"
PriceToBookRatio="3.399"
EVToRevenue="12.05"
EVToEBITDA="-5.31"
Beta="0.832"
num_52WeekHigh="12.98"
num_52WeekLow="2.57"
num_50DayMovingAverage="3.536"
num_200DayMovingAverage="7.82"
SharesOutstanding="53983000"
DividendDate="None"
ExDividendDate="None"
symbol="CARA"
open="2.66"
high="2.77"
low="2.61"
price="2.67"
volume="954961.00"
latest_trading_day="2023-07-10"
previous_close="2.67"
change="0.00"
change_percent="0.0000%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="100"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="0"
Volume_recent_avg="1148549"
Change_recent_avg="-0.05"
Delta_recent_avg="0.3"
Variance_recent_avg="0.15"
Change_ratio_recent_avg="-1.17"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="0"
Aroon_momentum_negative="100"
image_negative_thumbnail_id_1="109"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0067.jpeg"
image_negative_thumbnail_id_2="517"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0088.jpeg"
image_neutral_thumbnail_id_1="595"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0004.jpeg"
image_neutral_thumbnail_id_2="570"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0029.jpeg"
image_positive_thumbnail_id_1="663"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0045.jpeg"
image_positive_thumbnail_id_2="631"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0077.jpeg"
image_professor_thumbnail_id_1="1190"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0024.jpeg"
image_professor_thumbnail_id_2="1199"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0033.jpeg"
